| 0bd12f34-d4d4-47a7-986a-63136222cfa1 | <span class="null">NULL</span> | 0092175 | RADIOTERAPIA COM ACELERADOR LINEAR DE FÓTONS E ELÉTRONS ( POR CAMPO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 95ba4b23-def2-4dce-9afe-2a5d188397bd | <span class="null">NULL</span> | 0092176 | RADIOTERAPIA COM ACELERADOR LINEAR SÓ DE FOTONS ( POR CAMPO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f1b645a4-281f-450c-8836-8fbfcedc5c33 | <span class="null">NULL</span> | 0092177 | RADIOTERAPIA DE DOENÇA OU CONDIÇÃO BENIGNA (POR CAMPO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9f6eda18-5488-42ec-8f46-bcbc0617f603 | <span class="null">NULL</span> | 0092178 | RADIOTERAPIA ESTEREOTÁXICA FRACIONADA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b5f70520-c2ea-4d17-8dfc-19a2630c93a2 | 38a88f4f-e436-4ecf-89f9-eef9190588e4 | 0092179 | ROENTGENTERAPIA ( POR CAMPO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 62469706-5a9f-405d-b00f-f66638aa8b12 | 9ecde42c-2385-4323-bc74-26af165d0082 | 0092180 | SARCOMA OSSEO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c9bf4a84-104f-4a71-a78b-b5f1960a12a1 | d542c7ba-b906-4ea5-a3b6-36d88ea9c973 | 0092181 | SARCOMA DE PARTES MOLES - (G2 OU G3 TUMOR > 5 CM DE EXTREMID | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b11cdb0a-4325-4949-85b7-b4e74346a7b7 | 8e05c75f-0a97-4a54-8c7e-f69ad8911ed6 | 0092182 | SARCOMA DE PARTES MOLES (ESTADIO IV B OU RECIDIVA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 65349e31-d834-4e2d-8fb4-70aa2869006e | 7c5be591-b016-45d3-ba20-2ca4d060e6f4 | 0092183 | SARCOMA OSSEO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 29d6b797-cc60-478e-aab1-fe894445ead3 | 548b0e17-b6fa-4a39-a2f3-b4d663311e8a | 0092184 | SARCOMA OSSEO/OSTEOSSARCOMA 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 91bf143d-fefc-4021-85bc-60cf3841887f | c8d2e2df-819f-410c-b05a-0794fd911321 | 0092185 | TRICOLEUCEMIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c8f7803b-cc79-4068-b5ba-c09c3a24ce59 | 80542a38-f9db-49f0-8228-1fa4d78ff4f2 | 0092186 | TRICOLEUCEMIA (PROCEDIMENTO UNICO E EXCLUSIVO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6b54905d-ef5c-4d98-ba76-49483bb49542 | 4db16e48-9d13-43c4-9233-23aaed4ec191 | 0092187 | TUMOR DO ESTROMA GASTROINTESTINAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 3358aabc-5eb5-4674-bd2f-24918f276855 | dfccb2e2-6674-4261-aed0-91304756599a | 0092188 | TUMORES DO SISTEMA NERVOSO CENTRAL (GLIOMA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f729a750-11fd-414d-81a8-010b08f52381 | <span class="null">NULL</span> | 0092189 | TUMORES MALIGNOS DE TESTICULO - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b91d75a0-8c84-4098-945c-3a9247a24f5b | 8467c80c-8a50-47d0-beaa-e4066066c042 | 0092190 | TUMORES MALIGNOS DE TESTICULO - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a1571885-7d46-4c89-984f-db019160b4ff | 4503a8fd-993b-4c79-8098-714024b02d8f | 0092191 | VERIFICAÇÃO POR IMAGEM EM RADIOTERAPIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 05e61603-afb9-4a63-b412-4e87948e3be0 | c7f94e57-3f56-4b31-8d70-9583f24c07e6 | 0092192 | QUIMIOTERAPIA DE NEOPLASIA MALIGNA EPITELIAL DE OVÁRIO OU DE TUBA UTERINA AVANÇADA - 2ª LINHA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 67b02ad4-ee7b-456b-8c36-96e00b4fc4fd | 2e3a6759-6188-49f7-97e8-70108e92901a | 0092193 | QUIMIOTERAPIA DE TUMOR DO ESTROMA GASTRO INTESTINAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5bab4924-bf58-44fd-a55f-29bfd15a888c | 2c45b5d9-38af-4355-9bba-5f04caf45ab1 | 0092194 | QUIMIOTERAPIA DO CARCINOMA DE NASOFARINGE | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 194cc715-7547-48f3-93d5-ffaae85a065f | 39e54a82-7a33-4cb7-8f06-f78af8aae340 | 0092195 | QUIMIO D/LEUCEMIA LINFOIDE AGUDA /LINFOMA LINFOBLASTICO NA INFANCIA ADOLECENCIA 1° L+FASES INICIAIS | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 75556bbd-7e32-4d02-8b43-71239c26ec55 | 6a159032-b7b6-4a1c-86d7-e020bcad4dd6 | 0092196 | QUIMIO DE LEUCEMIA LINFOIDE AGUDA E LINFOMA LINFOBLASTICO NA INFANCIA ADOLECENCIA 1+L - MANUTENCAO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| be3721ae-b63c-4a7b-9767-cd4cd3f95185 | 973a7e3c-aeb4-4e2d-af98-8fc55ccf55d0 | 0092197 | POLIQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO ? 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 817c7111-f222-40ea-998a-e34f3d564aaf | 8467c80c-8a50-47d0-beaa-e4066066c042 | 0092198 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO ? 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2be5cccf-2adb-447b-a2e2-075dd03729d1 | 9ecde42c-2385-4323-bc74-26af165d0082 | 0092199 | QUIMIOTERAPIA DE NEOPLASIA MALIGNA EPITELIAL DE OVÁRIO OU DE TUBA UTERINA AVANÇADA -1ª LINHA. | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 3a926873-3392-4594-b9a4-af47cadc2a2e | d542c7ba-b906-4ea5-a3b6-36d88ea9c973 | 0092200 | QUIMIOTERAPIA DE NEOPLASIA MALIGNA EPITELIAL DE OVÁRIO OU DE TUBA UTERINA AVANÇADA - 2ª LINHA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 327f6212-230e-49d4-b3b1-4f9d1c9e31ef | c8d2e2df-819f-410c-b05a-0794fd911321 | 0092201 | QUIMIOTERAPIA DE SARCOMA DE PARTES MOLES AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| dfbbe0aa-6153-43ad-8bbf-bbb0e2241646 | 6a74ba8e-642b-497d-ad21-af18681ac388 | 0092202 | QUIMIOTERAPIA DE SARCOMA ÓSSEO AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a7d6de7f-1e97-461d-8163-8ffc781b7d03 | 691c7610-3aea-4fde-b260-ab1d73c34af4 | 0092203 | QUIMIOTERAPIA DO TUMOR DO ESTROMA GASTROINTESTINAL AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e64140d6-4772-4110-9cfb-9b9c5f731442 | 2c45b5d9-38af-4355-9bba-5f04caf45ab1 | 0092204 | QUIMIOTERAPIA DE CÂNCER NA INFÂNCIA E ADOLESCÊNCIA - 3ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b807955a-bbd7-4cc8-af38-b1318d006c6b | 2e3a6759-6188-49f7-97e8-70108e92901a | 0092205 | QUIMIOTERAPIA DE ALTA DOSE DE OSTEOSSARCOMA NA INFÂNCIA E ADOLESCÊNCIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b00865d9-789d-46a0-ab95-e11de2f2f88c | 8dbffd3c-86cf-46fa-bb0e-6408ad12664b | 0092206 | QUIMIO DE LEUCEMIA LINFOIDE AGUDA E LINFOMA LINFOBLÁSTICO NA INFÂNCIA ADOLECÊNCIA 1ª L.- MANUTENÇÃO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| d5cecce7-a56b-4fa5-a24f-fa3d115c8fce | a376e8a3-bf22-424b-bd4f-eb83b353946b | 0092207 | QUIMIO D/LEUCEMIA LINFOIDE AGUDA /LINFOMA LINFOBLÁSTICO NA INFÂNCIA ADOLECÊNCIA 1ª L.-FASES INICIAI | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bc6e4296-4894-4d5d-9b8f-645ddd81f26a | a0973ad7-c12d-488f-8c48-bb6e3ec5486f | 0092208 | QUIMIOTERAPIA DO ADENOCARCINOMA DE RETO (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| d4ad7835-8992-4d89-9ad6-9e1dba1f4900 | e8f5d085-ae33-4b7f-8bf3-25cf2cb56245 | 0092209 | HORMONIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO I | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a09f1934-2bb4-4071-a060-e6c0f5f3ee96 | 29ded6ca-1b0e-4db0-9500-6667aa655ba3 | 0092210 | QUIMIOTERAPIA DO CARCINOMA PULMONAR DE CÉLULAS NÃO PEQUENAS (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 59c75a69-8fb0-4b90-9853-8e30e3080803 | b93e4c5a-89a4-40b3-a608-53d94994cee1 | 0092211 | QUIMIOTERAPIA DE CARCINOMA PULMONAR INDIFERENCIADO DE CÉLULAS PEQUENAS (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c3f62b4c-2eb0-4364-9528-aebad24dc541 | 38a88f4f-e436-4ecf-89f9-eef9190588e4 | 0092212 | QUIMIOTERAPIA DE NEOPLASIA MALIGNA EPITELIAL DE OVÁRIO OU DA TUBA UTERINA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b372c54a-3506-4cdc-be6c-2cbe8e71a36c | 8e5fc06a-46f7-4d26-996c-bd3703245880 | 0092213 | QUIMIOTERAPIA DO OSTEOSSARCOMA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 8ea3b4d5-6e0c-4f1d-a51d-77b5291ac354 | 64a9ebf0-9d26-4b55-ac6d-b18c76dfc008 | 0092214 | QUIMIOTERAPIA DE SARCOMA DE PARTES MOLES DE EXTREMIDADE | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6b95b88a-20a5-4b23-8f9c-ddb6481393a7 | 1ad35e44-89a5-42c6-af97-6f4872fc9e33 | 0092215 | QUIMIOTERAPIA DA DOENÇA DE HODGKIN - 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 354050bd-dc0d-4a6b-8dc6-adf97ca15be5 | 651a0e64-53ef-41fd-a1de-93eadd616c85 | 0092216 | QUIMIOTERAPIA DA DOENÇA DE HODGKIN - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2a2ad8ad-8ac3-4263-8879-5b57c8f796e7 | 2ce11869-7e04-43f4-8756-cee860899591 | 0092217 | QUIMIOTERAPIA DA DOENÇA DE HODGKIN - 3ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bada8e11-c13e-4325-a0f4-37a184b90a4f | 4271f2fc-332e-4a1c-8768-1003e3db136f | 0092218 | QUIMIOTERAPIA DE LEUCEMIA AGUDA/ MIELODISPLASIA / LINFOMA DE BURKITT - 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fb5c5c63-d699-4c4c-8aa5-2bb4d350a069 | 466013b6-06b3-49f0-88c8-2bad549ed79a | 0092219 | QUIMIOTERAPIA DE LEUCEMIA AGUDA/ MIELODISPLASIA/LINFOMA LINFOBLÁSTICO/ LINFOMA DE BURKITT - 2ª LINH | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7768bdfe-a588-4c98-8931-ab8d3e6f9916 | 9368fdb1-1146-44d9-ac55-faaa21b921b4 | 0092220 | QUIMIOTERAPIA DE LINFOMA NÃO HODGKIN GRAU INTERMEDIÁRIO OU ALTO - 3ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 86600173-5882-4d3c-9f83-72aab8faeabd | df70dd45-6366-41bd-8028-d7f3a476bf04 | 0092221 | QUIMIOTERAPIA DE LINFOMA NÃO HODGKIN DE GRAU DE MALIGNIDADE INTERMEDIÁRIO OU ALTO - 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b471bab5-a896-4c4f-bceb-952cfc29cf3d | c865cea4-c4ee-494a-ba1f-1091be8f59fb | 0092222 | QUIMIOTERAPIA DE TUMOR GERMINATIVO EXTRA-GONADAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5a46e603-cc3d-4c82-b8e8-5b7786dd6dad | ad85e0c9-2e6a-450d-9cf4-259b400951d3 | 0092223 | QUIMIOTERAPIA DE TUMOR GERMINATIVO DE OVÁRIO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f5f7beb7-479a-42df-8b68-132404176cb0 | 4db16e48-9d13-43c4-9233-23aaed4ec191 | 0092224 | QUIMIOTERAPIA DE NEOPLASIA TROFOBLÁSTICA GESTACIONAL - BAIXO RISCO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |